The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min An Austin startup that has been ...

March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...

Following successful small-animal trials that confirmed bioequivalence, BioNxt is now taking the final preclinical step to prepare its sublingual Cladribine formulation for human testing. The upcoming ...

For more than a century, dentistry has focused on repairing or replacing damaged teeth, not growing new ones. That assumption is now under direct challenge, as Japanese teams move a first-of-its-kind ...

Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development. Earlier this week, the UK’s science minister announced an ambitious plan: to phase out ...